The Ras/ERK1–2 and RhoA/RhoA kinase signaling pathways and the HIF-1α/Pgp axis are more active in IGHV UM than M CLL cells. This evidence concerns the gene MAPK3 and B-cell chronic lymphocytic leukemia.